Company Overview of Aptuscan Ltd
Aptuscan Ltd., a biotechnology company, develops engineered proteins for pharmaceutical, biotechnology, and diagnostic companies. The company focuses on the development of Scannins binding agents for the diagnosis and treatment of disease. Its products represent a resource for the identification of binding agents for the development of therapeutics or diagnostics, or as research reagents. The company was founded in 2008 and is based in Leeds, United Kingdom. As of January 9, 2012, Aptuscan Ltd operates as a subsidiary of Avacta Group Plc.
Leeds Innovation Centre
103 Clarendon Road
Leeds, LS2 9DF
Founded in 2008
44 1133 845 858
44 1133 845 826
Key Executives for Aptuscan Ltd
Similar Private Companies By Industry
|ADC Biotechnology Ltd||Europe|
|Advanced Gel Technology Limited||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Aptuscan Ltd, please visit www.aptuscan.com. Company data is provided by Capital IQ. Please use this form to report any data issues.